A recent study published in the Journal of Cancer Research and Clinical Oncology explored genetic predictors of prostate cancer progression to help identify its clinical outcomes.
A major discovery by Australian researchers of a key driver of prostate cancer could lead to the next generation of targeted ...
Providence Alaska Medical Center will be the first in the state to offer Pluvicto, an innovative therapy for metastatic ...
“Prostate-specific membrane antigen (PSMA) PET imaging can identify patients suitable for PSMA-targeted radioligand therapy such as lutetium-177-PSMA-617. This is crucial for mCRPC patients who have ...
Explore how T cell engagers could transform cancer and autoimmune treatments through promising trials and key collaborations.
About half of men with medium-risk prostate cancer have just one tumour, occupying only 5 to 10 per cent of the prostate, yet ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...
Quality of life, treatment impact and duration, and the importance of individualized therapy are at the center of ...
Having raised more than $1 million toward cancer research over the past nine years, the tournament is on the road to raising $250,000 this year.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback